This paper is in the following e-collection/theme issue:

COVID-19 Vaccination (180) JMIR Theme Issue: COVID-19 Special Issue (2555) Public (e)Health, Digital Epidemiology and Public Health Informatics (1013) Vaccination and Immunization in the Digital Age (443) Infectious Diseases (non-STD/STI) (1727) Hygiene and Infection Prevention (374) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1543)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/48255, first published .
Durability of the Effectiveness of Heterologous COVID-19 Vaccine Regimens in Thailand: Retrospective Cohort Study Using National Registration Data

Durability of the Effectiveness of Heterologous COVID-19 Vaccine Regimens in Thailand: Retrospective Cohort Study Using National Registration Data

Durability of the Effectiveness of Heterologous COVID-19 Vaccine Regimens in Thailand: Retrospective Cohort Study Using National Registration Data

Authors of this article:

Ponlagrit Kumwichar1 Author Orcid Image ;   Chittawan Poonsiri2 Author Orcid Image ;   Siobhan Botwright2 Author Orcid Image ;   Natchalaikorn Sirichumroonwit3 Author Orcid Image ;   Bootsakorn Loharjun3 Author Orcid Image ;   Supharerk Thawillarp4 Author Orcid Image ;   Nontawit Cheewaruangroj5 Author Orcid Image ;   Amorn Chokchaisiripakdee5 Author Orcid Image ;   Yot Teerawattananon2 Author Orcid Image ;   Virasakdi Chongsuvivatwong1 Author Orcid Image
Article Authors Cited by (1) Tweetations (5) Metrics

Journals

  1. Saenwongsa W, Kingpha S, Saythanu P, Sopila S, Lertmemongkolchai G, Kewcharoenwong C. Impaired antibody responses to heterologous ChAdOx1 nCoV-19 and BNT162b2 vaccination in individuals with type 2 diabetes. Scientific Reports 2025;15(1) View